Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension

NCT00350844 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Low subject accrual

Conditions

Sickle Cell Disease
Pulmonary Hypertension

Interventions

DRUG: Hydroxyurea

Sponsor

Ann & Robert H Lurie Children's Hospital of Chicago